This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Ann-Muriel Steff: Innovator in Immunogenic Combinations
Introduction
Ann-Muriel Steff is a prominent inventor based in Laval, Canada. She has made significant contributions to the field of immunology, particularly through her innovative work on immunogenic combinations. Her research focuses on developing effective methods to elicit immune responses against respiratory pathogens.
Latest Patents
Ann-Muriel Steff holds 1 patent for her invention titled "Immunogenic combinations." This patent describes immunogenic combinations that include an immunogenic component containing a peptide or polypeptide antigen of a respiratory pathogen, along with another component containing a nucleic acid encoding an antigen of the same pathogen. The formulation is designed for concurrent administration, providing a novel approach to enhance immune responses specific to respiratory pathogens.
Career Highlights
Throughout her career, Ann-Muriel has demonstrated a commitment to advancing medical science. Her work at GlaxoSmithKline Biologicals SA has positioned her as a key player in the development of innovative vaccines and immunotherapies. Her research has the potential to significantly impact public health by improving the effectiveness of vaccines against respiratory diseases.
Collaborations
Ann-Muriel collaborates with esteemed colleagues, including Jean-Francois Toussaint and Alessandra Vitelli. These partnerships enhance her research efforts and contribute to the advancement of immunological studies.
Conclusion
Ann-Muriel Steff is a trailblazer in the field of immunogenic research, with her innovative patent paving the way for future advancements in vaccine development. Her contributions are vital in the ongoing fight against respiratory pathogens, showcasing the importance of innovation in healthcare.